A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
暂无分享,去创建一个
Jin-Zhi Du | Jun Wang | Tian-meng Sun | Pei-Zhuo Zhang | Er-Wei Song | Jin-Zhi Du | Cheng-Qiong Mao | Jun Wang | Tian-Meng Sun | Chengqiong Mao | Y. Yao | Pei-Zhuo Zhang | Yan-Dan Yao | Er-wei Song
[1] Y. Hannun,et al. Molecular targeting of acid ceramidase: implications to cancer therapy. , 2008, Current drug targets.
[2] J. Rossi,et al. RNA‐Mediated Inhibition of HIV in a Gene Therapy Setting , 2003, Annals of the New York Academy of Sciences.
[3] H. Uludaǧ,et al. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. , 2009, Biomaterials.
[4] G. Kwon,et al. Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins. , 2010, Molecular pharmaceutics.
[5] K. Knutson,et al. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[6] Dale L. Greiner,et al. T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2008, Cell.
[7] Svetlana Shulga Morskaya,et al. 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma , 2008, Nature Medicine.
[8] B. Davidson,et al. Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.
[9] T. Park,et al. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. , 2010, Biomaterials.
[10] Y. Iwasaki,et al. Enzyme-degradable phosphorylcholine porous hydrogels cross-linked with polyphosphoesters for cell matrices. , 2007, Biomaterials.
[11] L. Ellerby,et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Korsmeyer,et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.
[13] Leaf Huang,et al. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. , 2006, Molecular pharmaceutics.
[14] Y. Bae,et al. Self-assembled polyethylenimine-graft-poly(ε-caprolactone) micelles as potential dual carriers of genes and anticancer drugs , 2007 .
[15] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[16] A. Judge,et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA , 2005, Nature Biotechnology.
[17] A. Bielawska,et al. The functional effects of acid ceramidase over-expression in prostate cancer progression and resistance to chemotherapy , 2007, Cancer biology & therapy.
[18] S. Korsmeyer,et al. Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.
[19] X. Shuai,et al. Novel Biodegradable Ternary Copolymers hy-PEI-g-PCL-b-PEG: Synthesis, Characterization, and Potential as Efficient Nonviral Gene Delivery Vectors , 2003 .
[20] John J. Rossi,et al. The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.
[21] A. Huwiler,et al. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. , 2007, Critical reviews in oncology/hematology.
[22] A. Villanueva,et al. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo , 2007, Oncogene.
[23] Shubiao Zhang,et al. Cationic lipids and polymers mediated vectors for delivery of siRNA. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[24] Y. Bae,et al. Self-assembled polyethylenimine-graft-poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs. , 2007, Biomaterials.
[25] H. Uludaǧ,et al. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. , 2009, Molecular pharmaceutics.
[26] Judy Lieberman,et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.
[27] X. M. Sun,et al. Discrimination of apoptotic thymocytes by forward light scatter. , 1995, Cytometry.
[28] Yi-Yan Yang,et al. Synthesis and characterization of cationic micelles self-assembled from a biodegradable copolymer for gene delivery. , 2007, Biomacromolecules.
[29] R. Kontermann,et al. Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[30] Anna Moore,et al. In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.
[31] Judy Lieberman,et al. Interfering with disease: a progress report on siRNA-based therapeutics , 2007, Nature Reviews Drug Discovery.
[32] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[33] Jun Wang,et al. Functionalized micelles from block copolymer of polyphosphoester and poly(epsilon-caprolactone) for receptor-mediated drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[34] D. Kessel,et al. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage , 2002, Cell Death and Differentiation.
[35] N. Kosaka,et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. , 2004, Nucleic acids research.
[36] M. Tankersley,et al. T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2009, Pediatrics.
[37] Yi-Yan Yang,et al. The self-assembly of biodegradable cationic polymer micelles as vectors for gene transfection. , 2007, Biomaterials.
[38] X. M. Sun,et al. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. , 1992, The Biochemical journal.
[39] Anton P. McCaffrey,et al. Inhibition of hepatitis B virus in mice by RNA interference , 2003, Nature Biotechnology.
[40] H. Mao,et al. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. , 2008, Biomaterials.
[41] K. Baek,et al. Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[42] Ho Sup Yoon,et al. Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.
[43] C. Henderson,et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS , 2005, Nature Medicine.
[44] T. Tuschl,et al. The Human DiGeorge Syndrome Critical Region Gene 8 and Its D. melanogaster Homolog Are Required for miRNA Biogenesis , 2004, Current Biology.
[45] B. Williams,et al. Activation of the mammalian immune system by siRNAs , 2005, Nature Biotechnology.
[46] R. Kolesnick. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. , 2002, The Journal of clinical investigation.
[47] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[48] H. Rüdiger,et al. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. , 2001, Cancer research.
[49] M. Stevenson,et al. Modulation of HIV-1 replication by RNA interference , 2002, Nature.
[50] Jun Wang,et al. Biodegradable and photocrosslinkable polyphosphoester hydrogel. , 2006, Biomaterials.
[51] Yuanming Hu,et al. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] Mario Stevenson,et al. Therapeutic potential of RNA interference. , 2004, The New England journal of medicine.
[53] Leaf Huang,et al. Nonviral methods for siRNA delivery. , 2009, Molecular pharmaceutics.
[54] R. Juliano,et al. Biological barriers to therapy with antisense and siRNA oligonucleotides. , 2009, Molecular pharmaceutics.
[55] Mark E. Davis. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.
[56] G. Hannon,et al. Unlocking the potential of the human genome with RNA interference , 2004, Nature.
[57] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[58] Tatiana Segura,et al. Synthesis and in vitro characterization of an ABC triblock copolymer for siRNA delivery. , 2007, Bioconjugate chemistry.
[59] Judy Lieberman,et al. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs. , 2006, Annual review of biomedical engineering.
[60] John J. Rossi,et al. Strategies for silencing human disease using RNA interference , 2007, Nature Reviews Genetics.